Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Clinical Pharmacist

Learning and CPD

Management of migraines is individualised for each patient and there are a number of evidence and practiced-based treatments available. In the image, an elderly woman with a migraine consults with a doctor

Migraine managementSubscription

By , ,

Management of migraines is individualised for each patient and there are several evidence and practiced-based treatments available.

5HT1 receptor agonists (triptans) are used to treat acute migraine attacks. Despite their widespread use, clinically relevant interactions with 5HT1 receptor agonists are not frequently encountered. In the image, SPECT scan of a brain during a migraine

Triptan interactions Subscription

By , ,

A number of clinically relevant pharmacokinetic and pharmacodynamic interactions involving 5HT1 receptor agonists are known, although these are not frequently encountered in migraine treatment. 

This discussion, adapted from Integrated Pharmacy Case Studies, highlights some main questions to be considered in the case study. In the image, a middle-aged man holds his hands on his head

Case study: Differential indicators for migraine and medication-overuse headacheSubscription

By

Exploring questions to be considered when managing a patient with regular headaches.

Sickle cell disease is the most common inherited blood disorder in the UK, affecting 12,000–15,000 people. Although it is a life-shortening condition, its symptoms and complications can be effectively managed. Pictured, SEM of a sickle cell red blood cell

Sickle cell disease: symptoms, complications and managementSubscription

By

Sickle cell disease is the most common inherited blood disorder in the UK, affecting 12,000–15,000 people, and although it is a life-shortening condition, its symptoms and complications can be effectively managed.

Comment

Dementia is slowly reaching the top of government agendas globally, a move that has been long overdue. The condition affects 850,000 people in the UK and costs the UK economy £24bn a year. In the image, an elderly couple holds hands

Volunteers are vital to tackling dementiaSubscription

By

As research into dementia grows, so does the demand for research volunteers.

Update

First drug to improve sexual desire in women approved. In the image, Addyi pill bottle

Clinical Pharmacist’s monthly news round-up: the top 10 in the past monthSubscription

What has been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.

Career development

Pharmacy teams are often tasked with supporting other health professionals to optimise the way medicines are used. In the images, group of pharmacists and consultants in a meeting

How to develop a clinical resourceSubscription

By

Pharmacists may discover the need for a particular clinical resource in a variety of ways, including through daily practice and via learning events. Nina Barnett explains how to develop your idea into a useful tool for others.

Clinical Pharmacist

JSeptember 2015, Vol 7, No 8

Cover Story:

Management of migraines is individualised for each patient and there are several evidence and practiced-based treatments available.

Read more…

Clinical Pharmacist

View previous issue